Report copyright - Corporate Presentation - Hoth Therapeutics, Inc. · Expected annual sales of $8B+ by 2024 $4.9B 60% $1.3B $8B+ Pfizer acquired Anacor Premium over Anacor stock price Estimated sales
Please pass captcha verification before submit form